Donald Dobbins

University Hospitals Cleveland Medical Center

Papers

1

Total Citations

12

H-Index

1

About

Donald Dobbins is a radiation oncologist whose research focuses on the intersection of advanced radiation delivery techniques and the management of metastatic gynecologic malignancies. His most cited work, "Hematological Toxicity After Robotic Stereotactic Body Radiosurgery for Treatment of Metastatic Gynecologic Malignancies" (2012, 12 citations), represents a significant contribution to understanding the safety profile of stereotactic body radiosurgery (SBRT) in a vulnerable patient population. By systematically documenting hematological adverse effects, Dobbins provided critical data that helps clinicians balance the aggressive treatment of metastatic disease with the preservation of bone marrow function—a key concern in patients with prior chemotherapy or pelvic radiation. Though his citation count is modest, this work has informed clinical decision-making in radiation oncology, particularly for patients with recurrent or oligometastatic gynecologic cancers. Dobbins’ research underscores the importance of refining SBRT protocols to minimize toxicity while maximizing tumor control, a challenge that remains central to modern radiation oncology. His contributions highlight the ongoing need for evidence-based approaches to integrating advanced technologies into standard care.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Hematological Toxicity After Robotic Stereotactic Body Radiosurgery for Treatment of Metastatic Gynecologic Malignancies
12 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University Hospitals Cleveland Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago